The updated trial data shows three individuals with hemophilia B responding well to a one-time treatment with their investigational gene therapy AMT-061.
Senators Baldwin (D-WI) and Jones (D-AL) have introduced the No Junk Plans Act.
Researchers in Iran hope to achieve better outcomes for this vulnerable patient subgroup.
The investigators are working to build on factor VIIa’s established utility to stem bleeding, to one that can also prevent bleeding in both hemophilia A and B patients.
NHF has been leading efforts to fight co-pay accumulator programs since their inception.
Jumo Health and NHF seek to increase health literacy with the release four evidence-based comic books for those managing hemophilia.
Loss of patient protections would raise barriers to health insurance.
PAN Foundation and NHF announce new alliance to provide comprehensive support needed to best manage their disease.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car